CLASS II Device recall · Reported 29 Mar 2017 · FDA Enforcement Report

Merge Cardio recalled by Merge Healthcare

Merge Healthcare is recalling Merge Cardio, distributed in 10 states. The recall was initiated on 4 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVersion 9.0.9 and earlier using EchoIMS.
Quantity recalled17 sites potentially have the affected versions

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1415-2017
FDA event ID
76401
Recalling firm
Merge Healthcare, Hartland, WI
Classification
Class II
Status
Terminated
Recall initiated
4 Apr 2016
FDA classified
20 Mar 2017
Reported
29 Mar 2017
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Device Malfunction
Device type
Medical Software

Timeline

4 Apr 2016Recall initiated by company
20 Mar 2017Classified by FDA+350 days
29 Mar 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A situation can occur allowing two physicians to access the same study report in EchoIMS when launched from the Cardio Study List without receiving the read-only notification prompt.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Merge Cardio software using EchoIMS. The firm name on the label is Merge Healthcare, Hartland, WI.

Where it was distributed

US Distribution was made to medical facilities in CA, FL, IL, MD, MO, OH, OK, TX, VT, and WI. Military distribution was also made.

CaliforniaFloridaIllinoisMarylandMissouriOhioOklahomaTexasVermontWisconsin

Questions about this recall

Is Merge Cardio recalled?

Yes. Merge Healthcare recalled Merge Cardio on 4 Apr 2016. The recall is Class II and its status is Terminated. Recall number Z-1415-2017.

Why was it recalled?

A situation can occur allowing two physicians to access the same study report in EchoIMS when launched from the Cardio Study List without receiving the read-only notification prompt.

Which lots are affected?

Version 9.0.9 and earlier using EchoIMS.

Where was it sold?

US Distribution was made to medical facilities in CA, FL, IL, MD, MO, OH, OK, TX, VT, and WI. Military distribution was also made.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Merge Healthcare

All 96

Other Medical Software recalls

All 903